Plus   Neg

Canada's FSD Pharma Gets Health Canada's Cannabis Sales License

Canada-based FSD Pharma Inc. announced Monday that its subsidiary FV Pharma Inc. has received its Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada), with effect from April 18.

With the license, the current FSD facility can supply and sell cannabis products.

The company, which develops the highest quality indoor grown, pharmaceutical grade cannabis, expects to receive the amended sales license in the near future. The amended license will include the sale of dried and fresh cannabis flower.

FSD Pharma is also focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders.

Zeeshan Saeed, President and Founder, said, "We intend to quickly scale up production at our current facility, while continuing to build out the plant to add additional grow capacity. In addition, our sales license opens the door for our partner Canntab Therapeutics to commence sales of its suite of novel cannabis oral dose delivery platforms, including CBD and THC capsules, in Canada and global markets."

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT